nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—CYP2C19—Vismodegib—skin cancer	0.201	0.508	CbGbCtD
Glucosamine—CYP2E1—Dacarbazine—skin cancer	0.195	0.491	CbGbCtD
Glucosamine—MMP9—dermis—skin cancer	0.0429	0.126	CbGeAlD
Glucosamine—IFNG—skin epidermis—skin cancer	0.0281	0.0824	CbGeAlD
Glucosamine—MMP9—hindlimb—skin cancer	0.0253	0.0742	CbGeAlD
Glucosamine—MMP9—appendage—skin cancer	0.0217	0.0636	CbGeAlD
Glucosamine—IFNG—endothelium—skin cancer	0.0204	0.0598	CbGeAlD
Glucosamine—IFNG—blood vessel—skin cancer	0.0188	0.0552	CbGeAlD
Glucosamine—MMP9—skin epidermis—skin cancer	0.018	0.0529	CbGeAlD
Glucosamine—MMP9—endothelium—skin cancer	0.0131	0.0384	CbGeAlD
Glucosamine—MMP9—blood vessel—skin cancer	0.0121	0.0354	CbGeAlD
Glucosamine—NFKB2—mammalian vulva—skin cancer	0.0117	0.0344	CbGeAlD
Glucosamine—NFKB2—lymphoid tissue—skin cancer	0.0104	0.0305	CbGeAlD
Glucosamine—NFKB2—female reproductive system—skin cancer	0.01	0.0294	CbGeAlD
Glucosamine—IFNG—connective tissue—skin cancer	0.00964	0.0283	CbGeAlD
Glucosamine—IFNG—epithelium—skin cancer	0.00915	0.0269	CbGeAlD
Glucosamine—IFNG—skin of body—skin cancer	0.00871	0.0255	CbGeAlD
Glucosamine—MMP9—neck—skin cancer	0.00864	0.0253	CbGeAlD
Glucosamine—IFNG—lymphoid tissue—skin cancer	0.00705	0.0207	CbGeAlD
Glucosamine—IFNG—female reproductive system—skin cancer	0.0068	0.0199	CbGeAlD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TLR7—skin cancer	0.00678	0.0258	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—TLR7—skin cancer	0.00666	0.0253	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—TLR7—skin cancer	0.00643	0.0244	CbGpPWpGaD
Glucosamine—MMP9—connective tissue—skin cancer	0.00619	0.0182	CbGeAlD
Glucosamine—TNF—lymph node—skin cancer	0.00595	0.0175	CbGeAlD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.00592	0.0225	CbGpPWpGaD
Glucosamine—MMP9—epithelium—skin cancer	0.00588	0.0172	CbGeAlD
Glucosamine—NFKB2—lymph node—skin cancer	0.00587	0.0172	CbGeAlD
Glucosamine—IFNG—head—skin cancer	0.00568	0.0167	CbGeAlD
Glucosamine—MMP9—skin of body—skin cancer	0.00559	0.0164	CbGeAlD
Glucosamine—IFNG—IL2-mediated signaling events—RASA1—skin cancer	0.00501	0.019	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.00462	0.0176	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00457	0.0174	CbGpPWpGaD
Glucosamine—MMP9—lymphoid tissue—skin cancer	0.00453	0.0133	CbGeAlD
Glucosamine—MMP9—female reproductive system—skin cancer	0.00437	0.0128	CbGeAlD
Glucosamine—NFKB2—Neural Crest Differentiation—MITF—skin cancer	0.0042	0.016	CbGpPWpGaD
Glucosamine—IFNG—lymph node—skin cancer	0.00398	0.0117	CbGeAlD
Glucosamine—IFNG—Spinal Cord Injury—CSPG4—skin cancer	0.00397	0.0151	CbGpPWpGaD
Glucosamine—MMP9—head—skin cancer	0.00365	0.0107	CbGeAlD
Glucosamine—TNF—Adipogenesis—ASIP—skin cancer	0.00349	0.0133	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—PTCH1—skin cancer	0.00316	0.012	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—skin cancer	0.00311	0.0118	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CSPG4—skin cancer	0.00301	0.0114	CbGpPWpGaD
Glucosamine—IFNG—Calcium signaling in the CD4+ TCR pathway—PTGS2—skin cancer	0.00289	0.011	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—FOXO4—skin cancer	0.00265	0.0101	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.00261	0.00993	CbGpPWpGaD
Glucosamine—MMP9—lymph node—skin cancer	0.00255	0.00749	CbGeAlD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.00247	0.0094	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—RASA1—skin cancer	0.00244	0.00927	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—CDK4—skin cancer	0.00229	0.0087	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—TERT—skin cancer	0.00228	0.00868	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.00223	0.00846	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—PLIN2—skin cancer	0.00211	0.00804	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—skin cancer	0.00193	0.00732	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—PTGS2—skin cancer	0.00188	0.00714	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—skin cancer	0.00187	0.0071	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—BRAF—skin cancer	0.00185	0.00704	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CSPG4—skin cancer	0.00184	0.007	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.00174	0.00661	CbGpPWpGaD
Glucosamine—IFNG—IL27-mediated signaling events—IL6—skin cancer	0.00172	0.00653	CbGpPWpGaD
Glucosamine—IFNG—Cytokines and Inflammatory Response—IL6—skin cancer	0.00167	0.00633	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—SCN10A—skin cancer	0.00158	0.00599	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TERT—skin cancer	0.00153	0.00583	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—CDKN2A—skin cancer	0.00153	0.0058	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—skin cancer	0.00152	0.00578	CbGpPWpGaD
Glucosamine—CYP2E1—lymphoid tissue—skin cancer	0.00149	0.00437	CbGeAlD
Glucosamine—NFKB2—Innate Immune System—TLR7—skin cancer	0.00148	0.00563	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—PTGS2—skin cancer	0.00147	0.00558	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—FOXO4—skin cancer	0.00144	0.0055	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—IL6—skin cancer	0.00144	0.00549	CbGpPWpGaD
Glucosamine—CYP2E1—female reproductive system—skin cancer	0.00144	0.00422	CbGeAlD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—CDK4—skin cancer	0.00137	0.00522	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—NRAS—skin cancer	0.00137	0.00519	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—CDKN2A—skin cancer	0.00132	0.00502	CbGpPWpGaD
Glucosamine—NFKB2—TSLP Signaling Pathway—IL6—skin cancer	0.00132	0.00502	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CDK4—skin cancer	0.00131	0.005	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—IL6—skin cancer	0.00129	0.00492	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	0.00129	0.00491	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—NRAS—skin cancer	0.00129	0.00491	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—BRAF—skin cancer	0.00128	0.00486	CbGpPWpGaD
Glucosamine—NFKB2—Vitamin B12 Metabolism—IL6—skin cancer	0.00124	0.0047	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.00121	0.00461	CbGpPWpGaD
Glucosamine—CYP2E1—head—skin cancer	0.0012	0.00353	CbGeAlD
Glucosamine—IFNG—Selenium Micronutrient Network—PTGS2—skin cancer	0.00119	0.00452	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—KRAS—skin cancer	0.00118	0.00447	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	0.00116	0.00442	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CDKN2A—skin cancer	0.00116	0.0044	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SCN10A—skin cancer	0.00112	0.00428	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	0.00111	0.00422	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—KRAS—skin cancer	0.00111	0.00422	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CDKN2A—skin cancer	0.0011	0.00419	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—IL6—skin cancer	0.0011	0.00419	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—NRAS—skin cancer	0.0011	0.00419	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—skin cancer	0.0011	0.00418	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—skin cancer	0.00104	0.00395	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—IL6—skin cancer	0.00102	0.00389	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL6—skin cancer	0.00101	0.00382	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	0.001	0.00381	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—IL6—skin cancer	0.001	0.00381	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—HRAS—skin cancer	0.000999	0.0038	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—HRAS—skin cancer	0.000999	0.0038	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CDK4—skin cancer	0.000996	0.00379	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	0.000981	0.00373	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—NRAS—skin cancer	0.000968	0.00368	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—NRAS—skin cancer	0.000961	0.00366	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000947	0.0036	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.000944	0.00359	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—HRAS—skin cancer	0.000944	0.00359	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—PTGS2—skin cancer	0.000939	0.00357	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—RASA1—skin cancer	0.000937	0.00356	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000926	0.00352	CbGpPWpGaD
Glucosamine—TNF—Transcription factor regulation in adipogenesis—IL6—skin cancer	0.00091	0.00346	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—skin cancer	0.000908	0.00345	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—RASA1—skin cancer	0.000905	0.00344	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IL6—skin cancer	0.000903	0.00344	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—IL6—skin cancer	0.000891	0.00339	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—skin cancer	0.00089	0.00338	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—IL6—skin cancer	0.000886	0.00337	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—skin cancer	0.000866	0.00329	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR7—skin cancer	0.000862	0.00328	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RHOU—skin cancer	0.000859	0.00327	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—skin cancer	0.000859	0.00327	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000858	0.00326	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000851	0.00324	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000851	0.00324	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—skin cancer	0.000849	0.00323	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—KRAS—skin cancer	0.000833	0.00317	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—KRAS—skin cancer	0.000827	0.00315	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 cascade initiated on plasma membrane—IL6—skin cancer	0.000821	0.00312	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL6—skin cancer	0.000815	0.0031	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000813	0.00309	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000807	0.00307	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000805	0.00306	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000799	0.00304	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—skin cancer	0.000799	0.00304	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—skin cancer	0.000796	0.00303	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—skin cancer	0.000777	0.00296	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—skin cancer	0.000773	0.00294	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—skin cancer	0.000771	0.00293	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000771	0.00293	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—FOXO4—skin cancer	0.000762	0.0029	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	0.000758	0.00288	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—skin cancer	0.000748	0.00284	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—skin cancer	0.000735	0.0028	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—skin cancer	0.000727	0.00276	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000721	0.00274	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—PTGS2—skin cancer	0.000712	0.00271	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.00071	0.0027	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—HRAS—skin cancer	0.000708	0.00269	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—HRAS—skin cancer	0.000703	0.00267	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR7—skin cancer	0.000698	0.00266	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SCN10A—skin cancer	0.000689	0.00262	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.000685	0.0026	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—skin cancer	0.000678	0.00258	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—skin cancer	0.000674	0.00257	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—HRAS—skin cancer	0.000661	0.00251	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—skin cancer	0.000654	0.00249	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—skin cancer	0.000647	0.00246	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—RASA1—skin cancer	0.000646	0.00246	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—skin cancer	0.000643	0.00245	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	0.000642	0.00244	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.00062	0.00236	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	0.000615	0.00234	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—skin cancer	0.000614	0.00233	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDKN2A—skin cancer	0.000612	0.00233	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDK4—skin cancer	0.00061	0.00232	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—skin cancer	0.000601	0.00228	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—skin cancer	0.000589	0.00224	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—skin cancer	0.000587	0.00223	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—skin cancer	0.000584	0.00222	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—skin cancer	0.000562	0.00214	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—skin cancer	0.000559	0.00213	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000554	0.00211	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—skin cancer	0.000551	0.0021	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—skin cancer	0.000548	0.00208	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—skin cancer	0.000543	0.00206	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	0.00054	0.00205	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000527	0.002	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—skin cancer	0.000512	0.00195	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—skin cancer	0.000505	0.00192	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—skin cancer	0.000486	0.00185	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—NRAS—skin cancer	0.00048	0.00183	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000465	0.00177	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—skin cancer	0.000465	0.00177	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—skin cancer	0.000464	0.00176	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000452	0.00172	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—FOXO4—skin cancer	0.000444	0.00169	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—skin cancer	0.000436	0.00166	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—skin cancer	0.000424	0.00161	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTCH2—skin cancer	0.00042	0.0016	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000415	0.00158	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000414	0.00157	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—KRAS—skin cancer	0.000413	0.00157	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—skin cancer	0.000413	0.00157	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BRAF—skin cancer	0.000407	0.00155	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—RASA1—skin cancer	0.000396	0.0015	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000395	0.0015	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	0.000389	0.00148	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000389	0.00148	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—skin cancer	0.000388	0.00147	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—skin cancer	0.000378	0.00144	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000366	0.00139	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FOXO4—skin cancer	0.00036	0.00137	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—skin cancer	0.000358	0.00136	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000356	0.00135	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—skin cancer	0.000351	0.00134	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—skin cancer	0.00034	0.00129	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—skin cancer	0.000336	0.00128	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000331	0.00126	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GLI2—skin cancer	0.000318	0.00121	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CDK4—skin cancer	0.000317	0.0012	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—skin cancer	0.000316	0.0012	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000315	0.0012	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MC1R—skin cancer	0.000303	0.00115	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000303	0.00115	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—skin cancer	0.0003	0.00114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GLI1—skin cancer	0.000299	0.00114	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000297	0.00113	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000291	0.00111	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—skin cancer	0.00029	0.0011	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SUFU—skin cancer	0.000283	0.00108	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000268	0.00102	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000267	0.00101	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—skin cancer	0.000259	0.000987	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—skin cancer	0.000256	0.000975	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—skin cancer	0.000256	0.000972	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—skin cancer	0.000253	0.000964	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—skin cancer	0.000247	0.000939	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—skin cancer	0.000237	0.000903	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—skin cancer	0.00022	0.000837	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—skin cancer	0.00022	0.000836	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—skin cancer	0.000218	0.000829	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SHH—skin cancer	0.000216	0.000822	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RASA1—skin cancer	0.000215	0.000817	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—skin cancer	0.000212	0.000808	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—skin cancer	0.000209	0.000793	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000208	0.000792	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMO—skin cancer	0.000205	0.000779	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTCH1—skin cancer	0.000205	0.000779	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTGER4—skin cancer	0.0002	0.000759	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000199	0.000755	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—skin cancer	0.000196	0.000744	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CDK4—skin cancer	0.000194	0.000738	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—skin cancer	0.00019	0.000722	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—skin cancer	0.000185	0.000705	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—skin cancer	0.000181	0.000687	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—skin cancer	0.000177	0.000675	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000176	0.000671	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FOXO4—skin cancer	0.000176	0.00067	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—skin cancer	0.000176	0.00067	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—skin cancer	0.000173	0.000657	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLIN2—skin cancer	0.000168	0.00064	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—skin cancer	0.000152	0.000577	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—skin cancer	0.000148	0.000561	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CSPG4—skin cancer	0.000136	0.000516	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLIN2—skin cancer	0.00013	0.000494	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—skin cancer	0.000129	0.00049	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—skin cancer	0.000127	0.000483	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—skin cancer	0.000123	0.000469	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—skin cancer	0.00012	0.000455	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TERT—skin cancer	0.000118	0.000448	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—skin cancer	0.000108	0.000411	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—skin cancer	0.000108	0.00041	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CSPG4—skin cancer	0.000105	0.000398	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—skin cancer	0.000103	0.000393	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—skin cancer	0.000103	0.000391	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—BRAF—skin cancer	9.32e-05	0.000355	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—skin cancer	9.28e-05	0.000353	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO2—skin cancer	9.22e-05	0.000351	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—skin cancer	8.75e-05	0.000333	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—skin cancer	8.37e-05	0.000318	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—skin cancer	7.89e-05	0.0003	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—skin cancer	7.55e-05	0.000287	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO2—skin cancer	7.11e-05	0.00027	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—skin cancer	5.86e-05	0.000223	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.56e-05	0.000211	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ERCC2—skin cancer	5.35e-05	0.000204	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—skin cancer	5.04e-05	0.000192	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—skin cancer	4.48e-05	0.00017	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—skin cancer	4.29e-05	0.000163	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ERCC2—skin cancer	4.13e-05	0.000157	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—skin cancer	4.1e-05	0.000156	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—skin cancer	3.21e-05	0.000122	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—skin cancer	2.48e-05	9.42e-05	CbGpPWpGaD
